Sionna Therapeutics, Inc.
SION · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $668 | $0 | $0 |
| Gross Profit | -$668 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $57,288 | $40,626 | $34,605 |
| G&A Expenses | $13,268 | $9,707 | $6,767 |
| SG&A Expenses | $13,268 | $9,707 | $6,767 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | -$668 | $0 | $0 |
| Operating Expenses | $69,888 | $50,333 | $41,372 |
| Operating Income | -$70,556 | -$50,333 | -$41,372 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $8,868 | $3,070 | $1,132 |
| Pre-Tax Income | -$61,688 | -$47,263 | -$40,240 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$61,688 | -$47,263 | -$40,240 |
| % Margin | – | – | – |
| EPS | -1.4 | -1.071 | -0.912 |
| % Growth | -30.7% | -17.4% | – |
| EPS Diluted | -1.4 | -1.071 | -0.912 |
| Weighted Avg Shares Out | 44,124 | 44,124 | 44,124 |
| Weighted Avg Shares Out Dil | 44,124 | 44,124 | 44,124 |
| Supplemental Information | – | – | – |
| Interest Income | $8,170 | $2,769 | $1,132 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $668 | $583 | $122 |
| EBITDA | -$69,888 | -$49,750 | -$41,250 |
| % Margin | – | – | – |